Analyst Chris Thompson maintained a “Speculative Buy” rating on Turnium Technology Group (Turnium Technology Group Stock Quote, Chart, News, Analysts, Financials TSXV:TTGI) and raised his target price to $0.35 (from $0.30) in a May 25 eResearch report following what he described as an in-line fiscal Q2/2026 quarter and the first full reporting period reflecting the company’s combined platform strategy.
Thompson increased his target as Turnium continues integrating its acquisitions and shifts toward a broader Technology-as-a-Service model built around recurring revenue and operational leverage.
“FQ2/2026 marks the first quarter reflecting the fully reconstituted portfolio,” Thompson said.
Turnium reported fiscal Q2 revenue of $6.44-million, in line with Thompson’s $6.40-million estimate, representing the first full quarter consolidating Turnium Network Solutions, Claratti and Insentra. Adjusted EBITDA loss was $1.85-million, including roughly $470,000 in one-time M&A and financing costs that are not expected to recur in fiscal Q3.
Management reaffirmed guidance for revenue of $7.0-million to $7.5-million in fiscal Q3 and $8.0-million to $8.5-million in fiscal Q4, implying continued sequential growth toward a $28-million to $32-million annualized revenue run rate. The company has also launched a cost optimization program targeting $1.2-million to $2.4-million in annualized SG&A reductions to improve cash flow.
Thompson said post-quarter developments were encouraging, noting that Insentra secured two six-figure U.S. enterprise contracts structured as multi-phase engagements with recurring revenue potential.
“These wins validate Insentra’s enterprise credentials and channel-led growth model beyond its core Australian market,” Thompson said.
The analyst said the company’s transformation from a single-product SD-WAN vendor into a diversified technology services provider now gives it exposure to multiple growth areas, including managed networks, cybersecurity, UCaaS, maritime connectivity, AI implementation and post-quantum cybersecurity across North America, the U.K. and Asia-Pacific.
Still, Thompson said balance sheet repair remains the key risk. Total debt rose to $19.9-million, although about $7-million relates to vendor take-back loans and earn-outs tied to acquisitions. The company’s previously announced $6.0-million private placement is expected to fund approximately $2.5-million in debt repayment and $3.5-million in working capital.
Thompson said the company’s larger scale should improve profitability metrics materially.
“The $30-million revenue midpoint generates $12.4-million in gross profit, 185% more than FY2025’s $4.35-million, providing materially greater coverage of the fixed cost base and creating a credible path to the $2.1-million to $4.1-million Adjusted EBITDA guidance range,” he said.
Thompson said that Turnium should do $(6.7)-million in Adjusted EBITDA on revenue of $23.5-million in fiscal 2026. He said those numbers will improve to $3.4-million on revenue of $35.5-million in fiscal 2027.
-30-
On Oct. 22, Paradigm Capital analyst Marvin Wolff raised his target on CHAR Technologies (CHAR Technologies Stock Quote, Chart, News,… [Read More]
Stifel analyst Justin Keywood maintained his “Buy” rating and $44.00 target on ATS Corporation (ATS Corporation Stock Quote, Chart, News,… [Read More]
Markets have been choppy, but billionaire investor Bill Ackman sees the potential for a much stronger backdrop in 2027. Speaking… [Read More]
Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and $1.00 target on Atlas Engineered Products (Atlas Engineered Products Stock… [Read More]
Roth Capital Partners analyst Boobalan Pachaiyappan initiated coverage of Atrium Therapeutics (Atrium Therapeutics, Stock Quote, Chart, News, Analysts, Financials NASDAQ:RNA)… [Read More]
Goodreid Investment Counsel president and CEO Gordon Reid says Texas Instruments (Texas Instruments Stock Quote, Chart, News, Analysts, Financials NASDAQ:TXN)… [Read More]